Benoquin Cream contains Monobenzone, a member of the Depigmenting Agents group of medicines. It is primarily utilized to address the uneven skin appearance resulting from vitiligo, a condition characterized by the loss of skin color due to the depletion of brown pigment, leading to white patches on the skin.
Patients with a known allergy to Monobenzone should refrain from using Benoquin Cream. Additionally, it is contraindicated for individuals experiencing hyperpigmentation, skin discoloration from other pigments (such as sunspots, age spots, or freckles), or skin trauma.
Caution is advised when using Benoquin Cream in pregnant and breastfeeding women, only if deemed necessary by a healthcare professional. Similarly, consultation with a doctor is recommended before use in children and adolescents aged 12 to 18 years.
The most commonly reported side effects of Benoquin Cream include skin irritation and allergic contact dermatitis (skin rash). Should any of these side effects worsen, it is advisable to consult a doctor promptly.
USES OF BENOQUIN CREAM
Management of uneven skin appearance due to vitiligo
HOW BENOQUIN CREAM WORKS Benoquin Cream operates by reducing the melanin content (skin darkening pigment) in skin cells, thereby promoting uniformity in skin color among affected individuals, effectively managing the loss of skin color associated with vitiligo.
DIRECTIONS FOR USE
Apply Benoquin Cream as directed by your physician. It is intended for external use only. Prior to application, review the label for specific instructions. Avoid application near the eyes or eyelids. Your doctor will determine the appropriate dosage and duration based on factors such as age, body weight, and the severity of the condition.